Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

397 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Relevant issues in the pathology and pathobiology of pulmonary hypertension.
Tuder RM, Archer SL, Dorfmüller P, Erzurum SC, Guignabert C, Michelakis E, Rabinovitch M, Schermuly R, Stenmark KR, Morrell NW. Tuder RM, et al. Among authors: schermuly r. J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D4-12. doi: 10.1016/j.jacc.2013.10.025. J Am Coll Cardiol. 2013. PMID: 24355640 Free PMC article. Review.
Physiologic basis for the treatment of pulmonary hypertension.
Olschewski H, Olschewski A, Rose F, Schermuly R, Schütte H, Weissmann N, Seeger W, Grimminger F. Olschewski H, et al. Among authors: schermuly r. J Lab Clin Med. 2001 Nov;138(5):287-97. doi: 10.1067/mlc.2001.119329. J Lab Clin Med. 2001. PMID: 11709653 Review. No abstract available.
Cellular pathophysiology and therapy of pulmonary hypertension.
Olschewski H, Rose F, Grünig E, Ghofrani HA, Walmrath D, Schulz R, Schermuly R, Grimminger F, Seeger W. Olschewski H, et al. Among authors: schermuly r. J Lab Clin Med. 2001 Dec;138(6):367-77. doi: 10.1067/mlc.2001.119285. J Lab Clin Med. 2001. PMID: 11753283 Review.
Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective study.
Ghofrani HA, Voswinckel R, Reichenberger F, Olschewski H, Haredza P, Karadaş B, Schermuly RT, Weissmann N, Seeger W, Grimminger F. Ghofrani HA, et al. Among authors: schermuly rt. J Am Coll Cardiol. 2004 Oct 6;44(7):1488-96. doi: 10.1016/j.jacc.2004.06.060. J Am Coll Cardiol. 2004. PMID: 15464333 Free article. Clinical Trial.
Favorable effects of inhaled treprostinil in severe pulmonary hypertension: results from randomized controlled pilot studies.
Voswinckel R, Enke B, Reichenberger F, Kohstall M, Kreckel A, Krick S, Gall H, Gessler T, Schmehl T, Ghofrani HA, Schermuly RT, Grimminger F, Rubin LJ, Seeger W, Olschewski H. Voswinckel R, et al. Among authors: schermuly rt. J Am Coll Cardiol. 2006 Oct 17;48(8):1672-81. doi: 10.1016/j.jacc.2006.06.062. Epub 2006 Sep 26. J Am Coll Cardiol. 2006. PMID: 17045906 Free article. Clinical Trial.
Phosphodiesterase 1 upregulation in pulmonary arterial hypertension: target for reverse-remodeling therapy.
Schermuly RT, Pullamsetti SS, Kwapiszewska G, Dumitrascu R, Tian X, Weissmann N, Ghofrani HA, Kaulen C, Dunkern T, Schudt C, Voswinckel R, Zhou J, Samidurai A, Klepetko W, Paddenberg R, Kummer W, Seeger W, Grimminger F. Schermuly RT, et al. Circulation. 2007 May 1;115(17):2331-9. doi: 10.1161/CIRCULATIONAHA.106.676809. Epub 2007 Apr 16. Circulation. 2007. PMID: 17438150
Receptor for activated C-kinase 1, a novel interaction partner of type II bone morphogenetic protein receptor, regulates smooth muscle cell proliferation in pulmonary arterial hypertension.
Zakrzewicz A, Hecker M, Marsh LM, Kwapiszewska G, Nejman B, Long L, Seeger W, Schermuly RT, Morrell NW, Morty RE, Eickelberg O. Zakrzewicz A, et al. Circulation. 2007 Jun 12;115(23):2957-68. doi: 10.1161/CIRCULATIONAHA.106.670026. Epub 2007 May 21. Circulation. 2007. PMID: 17515463
397 results